The intermediate filament GFAP is important for the control of experimental murine Staphylococcus aureus-induced brain abscess and Toxoplasma encephalitis

J Neuropathol Exp Neurol. 2004 Jun;63(6):631-40. doi: 10.1093/jnen/63.6.631.

Abstract

The functional role of astrocytes exerted via their intermediate protein glial fibrillary acidic protein (GFAP) in CNS infections was studied in Staphylococcus aureus-induced brain abscess. Compared to wild type (WT) mice, GFAP(0/0) mice developed larger and more poorly demarcated inflammatory lesions paralleled by a significantly increased intracerebral bacterial load, a diffuse leukocytic infiltration of the contralateral hemisphere, purulent ventriculitis, vasculitis, and severe brain edema. These observations were correlated with the lack of a bordering function of activated astrocytes that strongly upregulated their GFAP expression in the abscess surrounding of WT mice. Clinically important, this lack of restriction of inflammation markedly aggravated the course of disease with manifestation of seizures and a severe weight loss in GFAP(0/0) mice. These data were paralleled by observations in the model of Toxoplasma encephalitis (TE) during which the intracerebral parasitic load was significantly increased. Moreover, tachyzoite-induced tissue necrosis was exclusively found in the brains of GFAP(0/0) mice in chronic TE. Collectively, these findings delineate a host defense function of astrocytes via restricting pathogenic spread and multiplication within the CNS, thereby contributing to the protection of the highly vulnerable brain parenchyma.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Abscess / genetics
  • Brain Abscess / metabolism
  • Female
  • Glial Fibrillary Acidic Protein / deficiency
  • Glial Fibrillary Acidic Protein / genetics
  • Glial Fibrillary Acidic Protein / physiology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Staphylococcal Infections / genetics
  • Staphylococcal Infections / metabolism*
  • Staphylococcal Infections / prevention & control
  • Staphylococcus aureus* / growth & development
  • Staphylococcus aureus* / pathogenicity
  • Toxoplasma* / growth & development
  • Toxoplasma* / pathogenicity
  • Toxoplasmosis, Animal / genetics
  • Toxoplasmosis, Animal / metabolism*
  • Toxoplasmosis, Animal / prevention & control

Substances

  • Glial Fibrillary Acidic Protein